MedTrace Logo

The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy

NCT03835039 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2022-03-15

No results posted yet for this study

Summary

A longitudinal study evaluating the predictive ability of near infrared spectroscopy to predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed at two different time periods, at discharge and again at 2 years of age.

Conditions

  • HIE - Perinatal Hypoxic - Ischemic Encephalopathy

Interventions

DEVICE

NIRS

Monitoring cerebral and perirenal perfusion using NIRS

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Albany Medical College

    lead OTHER

Eligibility

Min Age
1 Minute
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2022-01-01
Completion
2022-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03835039 on ClinicalTrials.gov